The gastric antisecretory activity of pyridyl-2-thioacetamide (CMN 131).
D000081:Acetamides / Q000494:pharmacology*; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D004285:Dogs; D005747:Gastric Fistula; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism*; D006632:Histamine / Q000494:pharmacology; D008026:Ligation; D008297:Male; D010418:Pentagastrin / Q000494:pharmacology; D011708:Pylorus / Q000601:surgery; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D013270:Stomach / Q000187:drug effects* / Q000601:surgery; D013853:Thioacetamide / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D000081:Acetamides; D011725:Pyridines; D013853:Thioacetamide; D006632:Histamine; D002217:Carbachol; D010418:Pentagastrin